AN ACT Relating to improving access to abortion medications;
Summary
SB 5917 is an act relating to improving access to abortion medications. It authorizes the Department of Corrections to acquire, receive, possess, sell, resell, deliver, dispense, and distribute abortion medications, and to do so for the benefit of any person, whether or not the person is in the department’s custody or supervision. The department is directed to establish and operate a program for delivery, dispensing, and distribution of these medications, and to coordinate with the Department of Health to identify appropriate recipients and prioritize bulk distribution to health care providers and entities, including Indian health care providers.
The bill defines “abortion medications” broadly to include medications used to induce termination of pregnancy or manage the full spectrum of reproductive health care, including mifepristone and misoprostol. It also specifies that deliveries to providers and entities must be for use in reproductive health care, including abortion care and medical management of early pregnancy loss. The act declares an emergency and takes effect immediately.
Impact
The bill amends Washington law to create a new authority and program within the Department of Corrections related to abortion medication distribution, and it exempts the department from obtaining a wholesalers license for actions taken under the new authority. It also sets pricing rules requiring sales and distribution at cost, with a limited fee to offset secure storage and delivery costs, and directs revenues under the relevant chapter to the general fund. The measure affects state agencies, health care providers, health care entities, and Indian health care providers by expanding access pathways for abortion medications and formalizing state involvement in their distribution.
Sentiment
The bill appears to have been generally favorable among lawmakers, as reflected in its passage through both chambers and committee votes. It passed the Senate on a 32-17 vote and the House on a 56-35 vote, with committee approval in the House Health Care & Wellness Committee and a narrow 2-2 vote in the Senate Human Services Committee on the substitute bill. The emergency clause and immediate effective date suggest supporters viewed the measure as time-sensitive and important for public health access.
Contention
The main point of contention is the bill’s subject matter: state involvement in abortion medication access. Supporters appear to have emphasized reproductive health access, including treatment for early pregnancy loss and distribution to health care providers and Indian health care entities. Opponents likely focused on abortion policy objections, the Department of Corrections’ unusual role in medication distribution, and the breadth of the definition of abortion medications. The close committee vote in the Senate and the relatively divided floor votes indicate meaningful disagreement, even though the bill ultimately passed.